Subset 0,Subset 1,Subset 2,Subset 3,Subset 4,Subset 5,Subset 6,Subset 7,Subset 8,Subset 9,Theme 0,Theme 1,Theme 2,Theme 3,Theme 4,Theme 5,Theme 6
Territory,NCT ID,Area,Country,City,Label,Source,Segmentation,Type,Status,"Opdivo, use of nivolumab, NSCLC, melano","BMS, TL, lung, R","data, Eliquis, regimen, apixab","combination, trial, pembrolizumab, effica","ipilimumab, PD-L1, agents, chemothera","toxicity, adverse events, progression, occ","tumor, OS, overall survival, respon"
